ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Weinstein Applauds Investigation Report

September 26, 1997

GM Foundation Awards Prizes

June 13, 2003

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

Shaky Start For FY11 Appropriations Cycle As Congress Feels Pressure to Cut Spending

June 4, 2010

Letters To The Editor From I-ELCAP’s Claudia Henschke and Steve Walker From Abigail Alliance.

July 8, 2011

DCT To Announce June 1 Guidelines For CREG Program In Cell Kinetics Related To Chemo, Radiotherapy

April 25, 1975